Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer von Korpal, Manav, Puyang, Xiaoling, Jeremy Wu, Zhenhua, Seiler, Roland, Furman, Craig, Oo, Htoo Zarni, Seiler, Michael, Irwin, Sean, Subramanian, Vanitha, Julie Joshi, Jaya, Wang, Chris K., Rimkunas, Victoria, Tortora, Davide, Yang, Hua, Kumar, Namita, Kuznetsov, Galina, Matijevic, Mark, Chow, Jesse, Kumar, Pavan, Zou, Jian, Feala, Jacob, Corson, Laura, Henry, Ryan, Selvaraj, Anand, Davis, Allison, Bloudoff, Kristjan, Douglas, James, Kiss, Bernhard, Roberts, Morgan, Fazli, Ladan, Black, Peter C., Fekkes, Peter, Smith, Peter G., Warmuth, Markus, Yu, Lihua, Hao, Ming-Hong, Larsen, Nicholas, Daugaard, Mads, Zhu, Ping

Volltext

H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma von Joshi, Jaya Julie, Coffey, Heather, Corcoran, Erik, Tsai, Jennifer, Huang, Chia-Ling, Ichikawa, Kana, Prajapati, Sudeep, Hao, Ming-Hong, Bailey, Suzanna, Wu, Jeremy, Rimkunas, Victoria, Karr, Craig, Subramanian, Vanitha, Kumar, Pavan, MacKenzie, Crystal, Hurley, Raelene, Satoh, Takashi, Yu, Kun, Park, Eunice, Rioux, Nathalie, Kim, Amy, Lai, Weidong G, Yu, Lihua, Zhu, Ping, Buonamici, Silvia, Larsen, Nicholas, Fekkes, Peter, Wang, John, Warmuth, Markus, Reynolds, Dominic J, Smith, Peter G, Selvaraj, Anand

Volltext

Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer von Korpal, Manav, Puyang, Xiaoling, Wu, Zhenhua Jeremy, Seiler, Roland, Furman, Craig, Oo, Htoo Zarni, Seiler, Michael, Irwin, Sean, Subramanian, Vanitha, Joshi, Jaya Julie, Wang, Chris K., Rimkunas, Victoria, Tortora, Davide, Yang, Hua, Kumar, Namita, Kuznetsov, Galina, Matijevic, Mark, Chow, Jesse, Kumar, Pavan, Zou, Jian, Feala, Jacob, Corson, Laura, Henry, Ryan, Selvaraj, Anand, Davis, Allison, Bloudoff, Kristjan, Douglas, James, Kiss, Bernhard, Roberts, Morgan, Fazli, Ladan, Black, Peter C., Fekkes, Peter, Smith, Peter G., Warmuth, Markus, Yu, Lihua, Hao, Ming-Hong, Larsen, Nicholas, Daugaard, Mads, Zhu, Ping

Volltext

H3B-6527 clinical biomarker assay development and characterization of HCC patient samples von Kumar, Pavan, Rimkunas, Vicki, Yu, Kun, Zhang, Zhaojie, MacKenzie, Crystal, Schindler, Joanne, Smith, Peter, Zhu, Ping, Selvaraj, Anand, Yu, Lihua, Das, Subhasree, Joshi, Jaya Julie

Volltext

Combined inhibition of FGFR4 and VEGFR signaling enhances efficacy in FGF19 driven hepatocellular carcinoma von Zhao, Xuesong, Joshi, Jaya Julie, Aird, Daniel, Karr, Craig, Yu, Kun, Huang, Chialing, Colombo, Federico, Virrankoski, Milena, Prajapati, Sudeep, Selvaraj, Anand

Volltext

Abstract 3126: H3B6527, a selective and potent FGFR4 inhibitor for FGF19-driven hepatocellular carcinoma von Selvaraj, Anand, Corcoran, Erik, Coffey, Heather, Prajapati, Sudeep, Hao, Ming-Hong, Larsen, Nicholas, Tsai, Jennifer, Satoh, Takashi, Ichikawa, Kana, Joshi, Julie Jaya, Hurley, Raelene, Wu, Jeremy, Huang, Chia-Ling, Bailey, Suzanna, Karr, Craig, Kumar, Pavan, Rimkunas, Victoria, Mackenzie, Crystal, Rioux, Nathalie, Kim, Amy, Akare, Sandeep, Lai, George, Yu, Lihua, Fekkes, Peter, Wang, John, Warmuth, Markus, Smith, Peter, Reynolds, Dominic

Volltext

In search of the mechanisms of ketamine's antidepressant effects: How robust is the evidence behind the mTor activation hypothesis [version 1; peer review: 1 approved, 1 approved w... von Popp, Susanna, Behl, Berthold, Joshi, Jaya Julie, Lanz, Thomas A, Spedding, Michael, Schenker, Esther, Jay, Therese M, Svenningsson, Per, Caudal, Dorian, Cunningham, Jacob I, Deaver, Daniel, Bespalov, Anton

Volltext

Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS von Benatar, Michael, Zhang, Lanyu, Wang, Lily, Granit, Volkan, Statland, Jeffrey, Barohn, Richard, Swenson, Andrea, Ravits, John, Jackson, Carlayne, Burns, Ted M., Trivedi, Jaya, Pioro, Erik P., Caress, James, Katz, Jonathan, McCauley, Jacob L., Rademakers, Rosa, Malaspina, Andrea, Ostrow, Lyle W., Wuu, Joanne

Volltext